Picture of Double Bond Pharmaceutical International AB (publ) logo

DBP B Double Bond Pharmaceutical International AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Double Bond Pharmaceutical International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
SAS
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-8.13-17.7-9.26-15.2-17.3
Depreciation
Non-Cash Items-0.325-0.513-1008.53
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3.290.098-0.9531.615.74
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Cash from Operating Activities-11.6-18-20-13.4-3.08
Capital Expenditures-0.136-0.502-0.3260
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items1.670-6.21
Purchase of Investments
Sale of Intangible Assets
Cash from Investing Activities-0.136-0.5021.340-6.21
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1328.615.93.3410.6
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.2310.1-2.83-101.33